Pertuzumab plus trastuzumab (P+T) in patients (pts) with bladder (BC) and ovarian cancer (OC) with ERBB2/3 alterations (alt): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) ...
The positions in the table below reflect the Translational Spatial Profiling Center (TPSC)'s position overall, domestically, within their sector, and in various subject areas based on their Share.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback